Literature DB >> 22019692

Safety assessment of yerba mate (Ilex paraguariensis) dried extract: results of acute and 90 days subchronic toxicity studies in rats and rabbits.

Fernanda de Andrade1, Claudia Almeida Coelho de Albuquerque, Marcelo Maraschin, Edson Luiz da Silva.   

Abstract

Acute toxicity of yerba mate dried extract (YMDE) was investigated in Wistar rats (6/sex/group) from single dose of 2g/kg body weight by intragastric administration and 14days monitoring. Subchronic toxicity was investigated in Wistar rats, by intragastric administration (10/sex/group), and in New Zealand rabbits by oral administration (3/sex/group) of 2g/kg body weight for 12weeks. Toxicological parameters included clinical signs, body weight, water, and food consumption, hematological and serum parameters, and histopathological assessment. Acute YMDE administration showed no effects on survival, clinical observations, macroscopic examination of organs, body weight or food, and water consumption. Sub-chronic administration of YMDE did not change behavior, body weight, and histopatological assessment of stomach, kidney, liver, and small gut. Moreover, most of biochemical and hematological parameters remained unchanged. In summary, the results of our preclinical toxicological investigation are indicative that the YMDE is well tolerated for both single and chronic administration.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019692     DOI: 10.1016/j.fct.2011.08.028

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Spray-Dried Yerba Mate Extract Capsules: Clinical Evaluation and Antioxidant Potential in Healthy Individuals.

Authors:  Aline Minuzzi Becker; Heloisa Pamplona Cunha; Antônio Corrêa Lindenberg; Fernanda de Andrade; Tales de Carvalho; Brunna Cristina Bremer Boaventura; Edson Luiz da Silva
Journal:  Plant Foods Hum Nutr       Date:  2019-12       Impact factor: 3.921

Review 2.  Hibiscus, Rooibos, and Yerba Mate for Healthy Aging: A Review on the Attenuation of In Vitro and In Vivo Markers Related to Oxidative Stress, Glycoxidation, and Neurodegeneration.

Authors:  Matheus Thomaz Nogueira Silva Lima; Eric Boulanger; Frédéric J Tessier; Jacqueline Aparecida Takahashi
Journal:  Foods       Date:  2022-06-07

3.  Ilex paraguariensis (yerba mate) improves endocrine and metabolic disorders in obese rats primed by early weaning.

Authors:  Natália da S Lima; Juliana G Franco; Nayara Peixoto-Silva; Lígia A Maia; Andrea Kaezer; Israel Felzenszwalb; Elaine de Oliveira; Egberto G de Moura; Patricia Cristina Lisboa
Journal:  Eur J Nutr       Date:  2013-02-09       Impact factor: 5.614

4.  Treatment with Ilex paraguariensis (yerba mate) aqueous solution prevents hepatic redox imbalance, elevated triglycerides, and microsteatosis in overweight adult rats that were precociously weaned.

Authors:  E de Oliveira; N S Lima; E P S Conceição; N Peixoto-Silva; E G Moura; P C Lisboa
Journal:  Braz J Med Biol Res       Date:  2018-05-21       Impact factor: 2.590

5.  The Effect of Ilex × meserveae S. Y. Hu Extract and Its Fractions on Renal Morphology in Rats Fed with Normal and High-Cholesterol Diet.

Authors:  Piotr Kuropka; Anna Zwyrzykowska-Wodzińska; Robert Kupczyński; Maciej Włodarczyk; Antoni Szumny; Renata M Nowaczyk
Journal:  Foods       Date:  2021-04-09

6.  Subchronic Toxicity Study of Alternanthera philoxeroides in Swiss Albino Mice Having Antioxidant and Anticoagulant Activities.

Authors:  Shahad Saif Khandker; Morshed Alam; Forhad Uddin; Ummay Mahfuza Shapla; Nafisa Lubna; Tanusree Amy Mazumder; Mahfuza Marzan; Milon Mondal; Md Ibrahim Khalil; Nurul Karim; Md Salman Shakil; Md Sakib Hossen
Journal:  J Toxicol       Date:  2022-07-13

Review 7.  A Critical Review on the Role of Food and Nutrition in the Energy Balance.

Authors:  Simona Bo; Maurizio Fadda; Debora Fedele; Marianna Pellegrini; Ezio Ghigo; Nicoletta Pellegrini
Journal:  Nutrients       Date:  2020-04-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.